XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
The AI-based software suite delivers fast and precise structural insights.
Themes
Lilly and insitro team up to develop AI-powered siRNA metabolic drugs
Oncolytics targets accelerated approval for oncolytic virus therapy
Resolution scores $83m to develop macrophage cell therapies
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication
Social media algorithms are driving the GLP-1 drugs boom
Exscientia outline robot and AI use in drug discovery workflow
Neffy nasal spray: a game changer for asthma patients and epinephrine delivery?
